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Objective: To determine the effect of Plantago major (P. major) extract on the liver
injury following acetaminophen (APAP) toxicity.
Methods: The male Sprague Dawley rats (n = 38) were randomly divided into normal
control (n = 6) and experiment (n = 32) groups. The latter was subdivided into four
groups and induced with APAP (1000 mg/kg) per oral, followed by P. major extract and
N-acetylcysteine orally to the respective groups for six days.
Results: On the seventh day, the serum bilirubin, liver enzymes and tissue malondial-
dehyde were increased in APAP groups whereas the total protein in serum, tissue su-
peroxide dismutase and glutathione levels were reduced. The plant extract treatment
reduced the histological deteriorations such as aggregation of hepatocellular cords, for-
mation of binucleated cells and vacuolisation of the cells with scanty cytoplasm. It also
revealed signiﬁcant reduction of malondialdehyde and increased level of superoxide
dismutase and glutathione. The ﬁndings in the extract treated groups were comparable to
the group treated with N-acetylcysteine.
Conclusions: In conclusion, P. major can enhance innate antioxidant activity and
ameliorate the APAP-induced liver injury.1. Introduction
Liver is susceptible to drug-induced injury owing to its major
role in drug metabolism. Several drugs such as antipyretics
including acetaminophen (APAP), anti-inﬂammatory drugs, anti-
tuberculosis drugs, antidepressants and anticancer drugs have po-
tential hepatotoxicity. The incidence of drug-induced liver diseases
is increasing day by day and unintentional drug toxicity is very
common nowadays all over the world. The drug-induced liver
diseases attribute more than 50% of acute liver failure [1]. The
APAP overdose is associated with high tendency of development
of acute liver failure [2]. The mechanism of APAP-induced hepa-
tocyte injury is owing to accumulation of its toxic metabolites, N-
acetyl-p-benzoquinone imine (NAPQI) which overshoots theneutralising capacity of the hepatic glutathione (GSH), resulting in
GSH depletion [3]. Therefore, the current treatment for APAP
toxicity is mainly focused to replace GSH with the precursor, N-
acetylcysteine (NAC). However, oxidative stress is one of the
contributing mechanisms in APAP toxicity [4]. Furthermore, the
efﬁcacy of NAC depends on timing of presentation after APAP
exposure [5]. Akhtar stated that the antidote should be given as
early as possible and the better prognosis would be seen when it
was initiated within 8 h following the exposure [6].
The natural products with antioxidant properties showed hep-
atoprotective activity against APAP toxicity [7,8]. Plantago major
(P. major), also known as greater plantain or broadleaf plantain, is
a medicinal herb with potent antioxidant effect [9]. It belongs to the
family of Plantaginaceae and iswidely found in Europe andAsia in
which Malaysia is one of the countries of its habitat. Its leaves are
large and ovate to elliptical shaped with parallel venation (5–9
veins). It contains polysaccharides, lipids, alkaloids, caffeic acid
derivatives and ﬂavonoids [10]. It is a popular herb of wound
healing [10]. Administration of this plant with the dose of 2
000 mg/kg showed no adverse effect [11]. The extensive in vitro
and in vivo studies showed its hypoglycaemic effect [12],
haemopoietic activity on the bone marrow and spleen cells [13],pen access article under the CC BY-NC-ND
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effect on Staphylococcus aureus and Escherichia coli and anti-
inﬂammatory properties [15,16]. Its hepatoprotective activity
against carbon tetrachloride (CCl4) toxicity has been observed
[17,18]. Based on the promising effect of P. major on liver injury,
the present study was aimed to explore its effect on APAP
toxicity and determine the potential protective mechanisms.
2. Materials and methods
2.1. Study design
Thirty-eight male Sprague Dawley rats (200–250 g) were
kept at room temperature (23–32 C) with 12 h light/dark cycle.
The rats were fed with rodent pellet (Gold Coin, Kepong,
Malaysia) and tap water ad libitum. The animals monitoring was
done in accordance with the institutional animal ethical guide-
line. The approval number was PP/ANAT/2010/KHIN/25-
NOVEMBER/340-NOVEMBER-2010-MAY 2012. The ani-
mals were acclimatised for one week. Then, they were randomly
divided into normal control (n = 6) and experiment (n = 32)
groups. The normal control (C) group was treated with 5%
dimethyl sulfoxide. The experiment group was subdivided into
APAP group which received 5% dimethyl sulfoxide, the extract
treated groups such as P. major extract in low dose (PML) and
P. major extract in high dose (PMH), and NAC treated group.
2.2. Plant extraction
P. major was collected from Cameron Highland, Malaysia
and was identiﬁed by an expert in the herbal centre of Faculty of
Science and Technology of the University. The leaves were
cleaned thoroughly with tap water and then dried up at the room
temperature. The dried leaves were weighed and processed for
methanol extraction with Soxhlet apparatus (Eyela CA 1312,
EM/EME/SERIES Electromantles, Thermoﬁsher Scientiﬁc,
United States). The rotary evaporator (Eyela N-1000, Canada)
was used to remove methanol. The extract was then collected
and kept in a 4 C freezer until further use.
2.3. Induction of liver toxicity and tissue collection
The animals were received oral APAP (1000 mg/kg) except C
group. The dose of APAP was selected based on Kiran et al. [19].
Twenty-four hours after the APAP ingestion, the rats in PML
and PMH groups were received P. major extract 1000 mg/kg and
1500 mg/kg respectively, and the NAC (900 mg/kg) for the NAC
group. The extract and NAC were given orally for six days
consecutively. OnDay 7, all the animals were sacriﬁced. The blood
and liver tissue were collected. The serum was sent to PATHLAB
to analyse liver enzymes such as aspartate aminotransferase (AST)
and alanine aminotransferase (ALT), bilirubin and total protein.
The liver tissue was weighed and observed for macroscopic
changes. Then, the part of liver tissue was kept in −80 C for
malondialdehyde (MDA), superoxide dismutase (SOD), and GSH
assays. The rest of the tissue was ﬁxed in 10% formalin.
2.4. Determination of MDA, hepatic SOD and GSH
The MDA assay kit (Biodivision, USA), SOD determination
kit (Sigma–Aldrich Chemie GmbH, Switzerland) and the GSHassay kit (Sigma–Aldrich, USA) were used and the analyses
were done according to the manufacturers' protocol.
2.4.1. Tissue MDA level
The tissue was homogenised in 300 mL of the MDA lysis
buffer with 3 mL butylated hydroxytoluene (100×) and subse-
quently centrifuged with 9000 r/min for 10 min to remove
insoluble material. The MDA in the sample was reacted with
thiobarbituric acid to generate the MDA-thiobarbituric acid
adduct which was detected by the microplate reader at 532 nm.
2.4.2. Tissue SOD level
For SOD determination, the tissue was homogenised and
centrifuged at 8000 r/min for 15 min and the supernatant was
collected. The SOD in the sample was determined by using
Dojindo's highly water soluble tetrazolium salt, WST-1 [2-(4-
Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetra-
zolium, monosodium salt] that produced a water-soluble for-
mazan dye upon reduction with a superoxide anion (Sigma
Aldrich, Switzerland). The absorbance was measured at 450 nm.
2.4.3. Tissue GSH level
The sample was deproteinised with 5-sulfosalicylic acid. The
GSH in liver tissue was measured by using kinetic assay in
which catalytic amounts of GSH (nmol) caused continuous
reduction of 5,50-dithiobis (2-nitrobenzoic acid) to 5-thio-2-
nitrobenzoic acid. The yellow product 5-thio-2-nitrobenzoic
acid was measured at 412 nm. The GSH level of liver was
expressed in nmol/mg.
2.5. Histological analysis
The tissue sample was ﬁxed in 10% formalin and processed
for histological analysis. The tissues were sectioned into 5 mm
thickness, stained with haematoxylin and eosin and observed
under light microscope.
2.6. Statistical analysis
The data were expressed as mean ± SEM and statistical
analysis was performed, by using ANOVA followed by post hoc
test (Tukey). The P value less than 0.05 was considered as
statistically signiﬁcant. The data analysis was done with SPSS
version 16.0 (SPSS Inc. Chicago, IL, USA).
3. Results
The body weight, the behaviour and physical activity of the
animals were monitored daily. The drastic drop of body weight
was found in experiment group after 24 h of induction. How-
ever, the body weight regained back to normal in all subgroups
at the end of the experiment. There was no macroscopic change
in the liver.
3.1. Serum biochemical parameters
The liver enzymes such as AST, and ALT, were remained
higher in APAP group compared to the PML, PMH and NAC
groups; however, it was not statistically signiﬁcant (P > 0.05).
The total bilirubin level was signiﬁcantly reduced in all the
treated groups such as PML, PMH and NAC compared to the
Table 1
Serum biochemical parameters following 7 days of treatment
(mean ± SEM).




C 124.40 ± 15.22 75.20 ± 6.25 3.00 ± 0.00a 68.16 ± 0.60
APAP 172.17 ± 19.72 78.33 ± 4.68 3.60 ± 0.21 66.50 ± 1.92
PML 119.83 ± 8.05 62.33 ± 2.60a 3.17 ± 0.17a 67.67 ± 1.20
PMH 132.17 ± 18.61 65.33 ± 1.93 3.00 ± 0.00a 69.50 ± 0.76
NAC 178.83 ± 25.12 67.67 ± 2.53 3.00 ± 0.00a 67.00 ± 0.45
a: Signiﬁcant difference compared to APAP group (P < 0.05).
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signiﬁcant change between APAP group and the treated groups
(P > 0.05) (Table 1).
3.2. Tissue MDA, SOD and GSH levels
The results of tissue MDA, SOD and GSH levels were shown
in Table 2.
The tissue MDA level was signiﬁcantly increased in the
APAP group compared to C group (P < 0.05). The PML and
PMH groups showed signiﬁcant reduction in MDA levelTable 2
Effect of P. major extract on the tissue MDA, SOD and GSH levels
(mean ± SEM).
Groups MDA (nmol/mg) SOD (IU/mL) GSH (nmol/mg)
C 1.33 ± 0.09a 1.220 ± 0.008a 1.32 ± 0.08
APAP 5.11 ± 0.22 0.890 ± 0.018 0.90 ± 0.16
PML 2.70 ± 0.17a,b 1.410 ± 0.196a,b 3.23 ± 0.04a,b
PMH 2.68 ± 0.18a,b 1.340 ± 0.007a 2.86 ± 0.06a,b
NAC 1.65 ± 0.60a 1.320 ± 0.008a 2.42 ± 0.10a
a: Signiﬁcant difference compared to APAP group (P < 0.05);
b: Signiﬁcant difference compared to C and NAC groups (P < 0.05).
Figure 1. Histological changes in liver tissue of APAP-induced liver toxicity
A: Normal histology of liver; B: C group showed normal hepatocytes cords radi
the CV with compressed sinusoidal space, presence of binucleated cells and
histology with obvious sinusoidal spaces; CV: Central vein.compared to the APAP group. The MDA level was signiﬁcantly
increased in the PML and PMH groups compared to the C and
NAC groups (P < 0.05).
The tissue SOD level was signiﬁcantly reduced in
the APAP group compared to the C group. The P. major
treated groups showed signiﬁcant increased level of SOD
compared to the APAP group. The PML group showed sig-
niﬁcant higher level of SOD compared to the NAC group
(P < 0.05).
The GSH level was signiﬁcantly higher in the PML, PMH
and NAC groups compared to that of the APAP group. In the
comparison among the treated groups, the plant extract treated
groups showed signiﬁcant higher GSH level than that of the
NAC group.
3.3. Histological analysis
The histological changes were observed and shown in
Figure 1. The tissue sample from the C group exhibited normal
liver architecture, revealing radiating hepatocyte cords from
the central vein to portal triad with sinusoidal spaces in be-
tween. In APAP group, the aggregation of hepatocytes was
found around the central vein, compressing the sinusoidal
spaces. The nuclei of hepatocytes became pale with frag-
mented nucleoli and the cytoplasm was scanty with vacuoli-
sation, revealing the features of steatosis. The cell membrane
of the hepatocytes was dissolved, resulting in fusion of two
cells to form binucleated cells. There was also an inﬁltration of
inﬂammatory cells around the portal triad and central vein. By
treating with the P. major extract, the hepatocytes revealed less
aggregation and less extent of vacuolisation. The sinusoidal
spaces in between the hepatocyte cords appeared wider
compared to APAP group. The PMH group showed more
histological improvement which was comparable with the
NAC and C groups. The evidence of histological features
revealed the lesser extent of liver injury in the P. major extract
treated groups compared to APAP group.(haematoxylin and eosin, × 100).
ating from the CV; C: APAP in which hepatocytes were aggregated around
vacuolisation; D: PML; E: PMH; F: NAC showed improvement in liver
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Liver is a site of drug metabolism. In APAP toxicity, hepa-
tocytes are exposed to excessive amount of toxic metabolites,
NAPQI, following depletion of GSH [20]. Hepatocyte injury
initiates the activation of tissue macrophages (Kupffer cells)
and stimulates the release of several inﬂammatory cytokines
and chemokines from the activated immune system. It is
triggered by tyrosine nitration and oxidative stress due to the
release of reactive oxygen species [4]. The reactive oxygen
species especially superoxide anions are accounted for the
formation of peroxynitrites and hydrogen peroxides (H2O2) [4].
The accumulation of H2O2 enhances the cell injury via lipid
peroxidation and the MDA is a reliable biomarker to
determine the extent of lipid peroxidation [4,21]. The innate
antioxidants such as SOD and the GSH, play an important
role to counter-check the oxidative stress. The SOD neutralises
the superoxide anions whereas the GSH is responsible to remove
H2O2 via glutathione peroxidase [22]. The cell injury in APAP
toxicity is owing to the excess amount of unconjugated
NAPQI which binds to the cellular protein of membrane-
bound cytoplasmic organelles such as mitochondria, endo-
plasmic reticulum and the nucleus, resulting in impaired cellular
function and cell death [20]. Therefore, the principle of current
drug treatment following APAP toxicity is to replace GSH.
The injured hepatocytes release cytosolic enzymes such as
AST and ALT, into the blood stream. The serum liver enzyme
levels were markedly increased within 6 h of drug exposure and
reached to the peak after 24 h [23]. The injured hepatocytes were
mainly found at the perivenous area which was observed as
cloudy swelling, vacuolisation, nuclear pyknosis and
fragmented nucleoli [24]. Those ﬁndings were observed in the
APAP group of our study. These injuries were commonly found
around the central vein because the CYP2E1, a key enzyme of
APAP metabolism was abundantly distributed around the
perivenous area [25]. However, hepatocytes can undergo
regeneration process under the circumstance of hepatotoxicity,
disease or surgery [26]. The serum liver enzymes will gradually
return to normal along with hepatocyte regeneration. Therefore,
the serum AST and ALT levels at Day 7 showed no signiﬁcant
difference in the present study. However, the APAP group
revealed the signiﬁcant higher level of MDA with histological
deterioration of liver architecture which indicated lipid
peroxidation attributed to the mechanism of hepatocyte injury.
The lower GSH level was also observed in this group.
Therefore, lipid peroxidation in APAP toxicity was due to
accumulation of H2O2 following hepatic GSH depletion which
leads to reduce efﬁcacy of glutathione peroxidase [22].
Moreover, the tissue SOD level was also low in the APAP
group. Our ﬁndings suggested that oxidative stress contributed
to the hepatocyte injury in the late presentation of APAP toxicity.
Therefore, the natural products with high antioxidant activity
might be considered as a potential alternative treatment for
APAP toxicity. The P. major leaf extract was used in the present
study. This plant is native to Europe and is a popular edible
weed because of its wound-healing property [10]. In the United
States, it is known as “white man's footprint”. P. major
possesses several bioactive compounds [10]. Its antioxidant and
free radical scavenging activity are contributed by its total
phenol contents, ﬂavonoids and caffeic acid derivatives such
as plantamajoside and acteoside [10]. Although the
hepatoprotective studies have been done previously, thosewere done on CCl4-induced liver injury and P. major was
given prior to CCl4 exposure [17,18]. Based on the promising
effect of P. major on liver injury, we took up the challenge of
real case scenario and P. major was given after APAP
toxicity. We found that the P. major extract treated groups
showed higher GSH level and increased SOD activity than the
C and NAC groups. Moreover, the low MDA level was also
observed in these groups. Our results proved that the P. major
extract attenuated the lipid peroxidation and enhanced innate
antioxidants. Thus, the P. major treatment not only prevents
the GSH depletion but also reduces the oxidative stress.
Among the experiment groups, the PML group showed
signiﬁcant lower level of ALT. It also revealed signiﬁcant
lower level of MDA as well as higher level of SOD and GSH
compared to the experiment group. Moreover, the only mild
histological changes were observed in the liver tissue of the
PML group. Therefore, the low dose (1000 mg/kg) of
P. major crude extract is recommended for future application.
As a conclusion, the P. major extract showed hepatoprotective
effect against APAP toxicity. The potential mechanism of this
effect is by enhancing the activities of innate antioxidants. The
further studies are required to explore its effect on the
NAPQI-protein binding status, GSH synthesis and the activ-
ities of enzymes such as CYP2E1, catalase and GSH peroxidase.
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